Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma. [electronic resource]
Producer: 20130627Description: 402-9 p. digitalISSN:- 1520-4383
- Aged
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor
- Clinical Trials as Topic
- Cyclophosphamide -- therapeutic use
- Doxorubicin -- therapeutic use
- Female
- Gene Expression Profiling
- Humans
- Lymphoma, Large B-Cell, Diffuse -- blood
- Male
- Medical Oncology -- methods
- Middle Aged
- Prednisone -- therapeutic use
- Prognosis
- Rituximab
- Time Factors
- Treatment Outcome
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.